Alvotech first biosimilar product, version of Humira, enrolls first patient in study
Alvotech has enrolled the first patient to test its Humira biosimilar candidate in Alvopad PS, in a Phase III clinical study (ALVOPAD PS), for adult patients with moderate to severe chronic plaque psoriasis.